Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 7
1965 36
1966 215
1967 428
1968 543
1969 687
1970 712
1971 776
1972 878
1973 1033
1974 1104
1975 1110
1976 1296
1977 1237
1978 1168
1979 1266
1980 1366
1981 1362
1982 1461
1983 1489
1984 1560
1985 1531
1986 1347
1987 1344
1988 1317
1989 1394
1990 1223
1991 1175
1992 1018
1993 913
1994 815
1995 767
1996 686
1997 631
1998 604
1999 612
2000 580
2001 447
2002 473
2003 501
2004 473
2005 462
2006 474
2007 465
2008 456
2009 493
2010 570
2011 629
2012 596
2013 628
2014 645
2015 661
2016 531
2017 578
2018 576
2019 553
2020 580
2021 276
Text availability
Article attribute
Article type
Publication date

Search Results

45,524 results
Results by year
Filters applied: . Clear all
Page 1
Propranolol.
Al-Majed AA, Bakheit AHH, Abdel Aziz HA, Alajmi FM, AlRabiah H. Al-Majed AA, et al. Profiles Drug Subst Excip Relat Methodol. 2017;42:287-338. doi: 10.1016/bs.podrm.2017.02.006. Epub 2017 Apr 6. Profiles Drug Subst Excip Relat Methodol. 2017. PMID: 28431779
Propranolol is a noncardioselective beta-blocker. It is reported to have membrane-stabilizing properties, but it does not own intrinsic sympathomimetic activity. Propranolol hydrochloride is used to control hypertension, pheochromocytoma, myocardial infarction, card
Propranolol is a noncardioselective beta-blocker. It is reported to have membrane-stabilizing properties, but it does not own intrins
β-blocker therapy for infantile hemangioma.
Koh SP, Leadbitter P, Smithers F, Tan ST. Koh SP, et al. Expert Rev Clin Pharmacol. 2020 Aug;13(8):899-915. doi: 10.1080/17512433.2020.1788938. Expert Rev Clin Pharmacol. 2020. PMID: 32662682 Review.
AREAS COVERED: The demonstration of a hemogenic endothelium origin of IH, with a neural crest phenotype and multi-lineage differentiation capacity, regulated by the renin-angiotensin system, underscores its programmed biologic behavior and accelerated involution induced by pro
AREAS COVERED: The demonstration of a hemogenic endothelium origin of IH, with a neural crest phenotype and multi-lineage differentiation ca …
Propranolol therapy for infantile hemangioma: our experience.
Zhang L, Wu HW, Yuan W, Zheng JW. Zhang L, et al. Drug Des Devel Ther. 2017 May 8;11:1401-1408. doi: 10.2147/DDDT.S134808. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 28507428 Free PMC article.
Here, we evaluated the efficacy of propranolol on proliferation IH in a clinical cohort including 578 patients. METHODS: We retrospectively reviewed a total of 578 IH patients who were treated with oral propranolol from January 2010 to December 2012. Responses to th …
Here, we evaluated the efficacy of propranolol on proliferation IH in a clinical cohort including 578 patients. METHODS: We retrospec …
Two dimensional chromatography mass spectrometry: Quantitation of chiral shifts in metabolism of propranolol in bioanalysis.
Harps LC, Schipperges S, Bredendiek F, Wuest B, Borowiak A, Parr MK. Harps LC, et al. J Chromatogr A. 2020 Apr 26;1617:460828. doi: 10.1016/j.chroma.2019.460828. Epub 2019 Dec 26. J Chromatogr A. 2020. PMID: 31911001
In this study a heart-cutting 2D-LC method was successfully developed and optimized in order to discriminate and quantitate (S)-propranolol, (R)-propranolol, and its hydroxy metabolites, namely the isomeric (S)-4'-hydroxy propranolol, (R)-4'-hyd …
In this study a heart-cutting 2D-LC method was successfully developed and optimized in order to discriminate and quantitate (S)-pr
Propranolol.
[No authors listed] [No authors listed] Br Med J. 1966 Nov 26;2(5525):1311-2. Br Med J. 1966. PMID: 5924821 Free PMC article. No abstract available.
Propranolol.
[No authors listed] [No authors listed] Lancet. 1967 Apr 29;1(7496):939-40. Lancet. 1967. PMID: 4164409 No abstract available.
Propranolol's effects on the sleep of infants with hemangiomas: A prospective pilot study.
Frost S, Saddi V, Teng A, Mallitt KA, Adams S, Williamson B, Wargon O. Frost S, et al. Pediatr Dermatol. 2021 Mar;38(2):371-377. doi: 10.1111/pde.14484. Epub 2020 Dec 22. Pediatr Dermatol. 2021. PMID: 33351238
OBJECTIVE: To assess propranolol's impact on sleep when used in infants and toddlers with infantile hemangioma (80% under 6 months old). METHODS: Parents and caregivers of infants and toddlers with infantile hemangioma presenting to a tertiary pediatric hospital' …
OBJECTIVE: To assess propranolol's impact on sleep when used in infants and toddlers with infantile hemangioma (80% under 6 mo …
Methods and approaches for determination and enantioseparation of (RS)-propranolol.
Batra S, Bhushan R. Batra S, et al. Biomed Chromatogr. 2019 Jan;33(1):e4370. doi: 10.1002/bmc.4370. Epub 2018 Sep 30. Biomed Chromatogr. 2019. PMID: 30121955 Review.
Propranolol, a beta-adrenergic receptor antagonist, is a chiral compound that is marketed as a racemate, but only the (S)-(-)-enantiomer is responsible for the beta-adrenoceptor blocking activity. Different chromatographic methods have been applied for separation an
Propranolol, a beta-adrenergic receptor antagonist, is a chiral compound that is marketed as a racemate, but only the (S)-(-)-
Propranolol disrupts consolidation of emotional memory in Lymnaea.
Shymansky T, Hughes E, Rothwell CM, Lukowiak K. Shymansky T, et al. Neurobiol Learn Mem. 2018 Mar;149:1-9. doi: 10.1016/j.nlm.2018.01.010. Epub 2018 Feb 3. Neurobiol Learn Mem. 2018. PMID: 29412170
Mixed results have been published regarding propranolol's ability to disrupt the consolidation and reconsolidation of memories. ...These data suggest that the time of propranolol administration, as well as the type of memory formed play a key role in propr
Mixed results have been published regarding propranolol's ability to disrupt the consolidation and reconsolidation of memories …
Safety and effectiveness of propranolol in severely burned patients: systematic review and meta-analysis.
Manzano-Nunez R, García-Perdomo HA, Ferrada P, Ordoñez Delgado CA, Gomez DA, Foianini JE. Manzano-Nunez R, et al. World J Emerg Surg. 2017 Mar 2;12:11. doi: 10.1186/s13017-017-0124-7. eCollection 2017. World J Emerg Surg. 2017. PMID: 28265298 Free PMC article. Review.
CONCLUSIONS: Our analysis indicates that there were no differences in mortality or sepsis in severely burned patients treated with propranolol compared with those who had usual care or placebo. However, the use of propranolol in these patients resulted in lower requ …
CONCLUSIONS: Our analysis indicates that there were no differences in mortality or sepsis in severely burned patients treated with propra
45,524 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page